Most Popular Stories
- UnitedHealth reveals details of option back-dating settlement
- DOD, VA move to SOA architecture to build interoperable systems
- Social Security wants EMR access for disability determination
- Another attempt to halt Horizon BCBS of NJ's switch to for-profit
- Study: EMRs can cut paid malpractice settlements
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- AHA survey: Negative profit margins for hospitals
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Healthcare on track to set record for mass layoffs
- DOD, VA move to SOA architecture to build interoperable systems
- Study: EMRs can cut paid malpractice settlements
- Signs of trouble in the Motor City
Poll
Featured Jobs
-
Illinois Hospitalist
StaffPointe, LLC - northeast , IL -
Tennessee Rheumatologist
StaffPointe, LLC - near Chattanooga , TN -
Tennessee Family Practice
StaffPointe, LLC - east , TN -
Texas Hospitalist
StaffPointe, LLC - south , TX -
Georgia Invasive Cardiologist
StaffPointe, LLC - southeast coast , GA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
Medicare's needy struggle to get drugs
According to some advocacy groups, it looks like pharma companies aren't coming up with free prescription drugs for the needy Medicare recipients, despite a pointed congressional request eight months ago. Several pharma companies had called off their drug assistance programs for Medicare patients once Part D became effective last year. The drug makers said that they were afraid they'd be accused of violating anti-kickback rules if they kept the programs open, though CMS has since said that the programs can be set up in a way that won't expose them to kickback accusations.
To date, about half of the members of the Pharmaceutical Research and Manufacturers of America have gone back to offering assistance to needy Medicare members, including AstraZeneca, GlaxoSmithKline, Merck, Pfizer and Wyeth. Still, that leaves another 50 percent who aren't involved. Legislators haven't reached the point of pushing harder regarding the free drug program issue, but it wouldn't surprise anyone if a newly-installed Democratic Congress took the issue on again shortly.
For more information on the free Medicare drug issue:
- read this item from The Tennessean
Related Article:
House passes Medicare drug negotiation bill. Report
Dems tackle Medicare drug costs. Report
Related Stories
- Study: Pharma disclosure laws not working
- Employers offering free meds for chronic diseases
- Vaccine development surges
- Medicare lab test pilot on hold
- CMS says doctors earned $16.7M on P4P demo
- Drugmakers agree to six-month DTC delay
- Medicare releases volume, customer satisfaction data
- SPOTLIGHT: Pfizer, GSK hike prices to boost sales
- Senators ask CMS to keep disease-mgmt program
- Merck agrees to pay$650M+ to settle suits
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





